Tanaka Hiroaki, Hasegawa Junichi, Katsuragi Shinji, Tanaka Kayo, Arakaki Tatsuya, Nakamura Masamitsu, Hayata Eijiro, Nakata Masahiko, Sekizawa Akihiko, Ishiwata Isamu, Ikeda Tomoaki
Department of Obstetrics and Gynecology, Mie University School of Medicine, Edobashi 2-174, Tsu 514-8507, Mie, Japan.
Japan Maternal Death Exploratory Committee, Ichigayahachimantyou 14, Shinjuku, Tokyo 162-0844, Japan.
J Clin Med. 2023 Apr 17;12(8):2908. doi: 10.3390/jcm12082908.
Unlike Europe and the United States, Japan has seen numerous maternal deaths from hemorrhagic strokes related to hypertensive disorders of pregnancy (HDP). This study retrospectively analyzed deaths associated with HDP-related hemorrhagic stroke in Japan to determine the number of deaths that may have been prevented with blood pressure control during pregnancy.
This study included maternal deaths related to hemorrhagic stroke cases. The proportion of patients without proteinuria whose blood pressure exceeded 140/90 mmHg between 14+0 and 33+6 weeks of gestation were determined. Lastly, the application of tight antihypertensive management was evaluated.
Among 34 HDP-related maternal deaths, 4 cases involved patients without proteinuria whose blood pressures exceeded 140/90 mmHg between 14+0 and 33+6 weeks of gestation. These included two chronic hypertension and two gestational hypertension cases. None of the patients received antihypertensive agents, and their blood pressures were managed leniently.
Among HDP-related hemorrhagic stroke deaths in Japan, only a few cases of maternal death could have been prevented with tight blood pressure management, as described in the CHIPS randomized controlled trial. Therefore, to prevent HDP-related hemorrhagic stroke in Japan, new preventive strategies during pregnancy should be established.
与欧洲和美国不同,日本有许多与妊娠高血压疾病(HDP)相关的出血性中风导致的孕产妇死亡。本研究回顾性分析了日本与HDP相关的出血性中风导致的死亡情况,以确定在孕期通过控制血压可能预防的死亡人数。
本研究纳入了与出血性中风病例相关的孕产妇死亡。确定了在妊娠14 + 0周至33 + 6周之间血压超过140/90 mmHg且无蛋白尿的患者比例。最后,评估了严格降压管理的应用情况。
在34例与HDP相关的孕产妇死亡中,有4例患者在妊娠14 + 0周至33 + 6周之间血压超过140/90 mmHg且无蛋白尿。其中包括2例慢性高血压和2例妊娠期高血压病例。所有患者均未接受抗高血压药物治疗,其血压管理较为宽松。
在日本与HDP相关的出血性中风死亡病例中,如CHIPS随机对照试验所述,通过严格的血压管理仅能预防少数孕产妇死亡病例。因此,为预防日本与HDP相关的出血性中风,应制定孕期新的预防策略。